Recent News

• 06.11.2025 - Hyperfine Announces Key Executive Appointments to Strengthen its Leadership Position in AI-Powered Portable MRI
• 06.11.2025 - Hyperfine Announces Key Executive Appointments to Strengthen its Leadership Position in AI-Powered Portable MRI
• 06.04.2025 - Jefferies Global Healthcare Conference
• 06.04.2025 - Jefferies Global Healthcare Conference
• 06.02.2025 - Hyperfine Announces FDA Clearance of a New Next-Generation Swoop® System Powered by Optive AI™ Software, Delivering a Transformative Leap in Image Quality
• 06.02.2025 - Hyperfine Announces FDA Clearance of a New Next-Generation Swoop® System Powered by Optive AI™ Software, Delivering a Transformative Leap in Image Quality
• 05.28.2025 - Hyperfine Announces FDA Clearance of Optive AI™ Software, Introducing the Most Substantial Image Quality Improvement Ever for the Swoop® System
• 05.28.2025 - Hyperfine Announces FDA Clearance of Optive AI™ Software, Introducing the Most Substantial Image Quality Improvement Ever for the Swoop® System
• 05.15.2025 - Hyperfine, Inc. to Participate in Upcoming Jefferies Global Healthcare Conference
• 05.15.2025 - Hyperfine, Inc. to Participate in Upcoming Jefferies Global Healthcare Conference

Recent Filings

• 06.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.23.2025 - 8-K Current report
• 05.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.19.2025 - 8-K Current report
• 05.16.2025 - 4 Statement of changes in beneficial ownership of securities